arrow
A

Ana Maria Gheorghiu

carol davila university of medicine & pharmacy
H指数:16
被引数:600

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of oral anticoagulants in precapillary pulmonary hypertension associated with systemic sclerosis: a EUSTAR cohort study

系统性硬化症相关肺动脉高压患者口服抗凝剂的有效性:一项EUSTAR队列研究

2026-09-180
OAAI
The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort

羟氯喹对系统性硬化病患者日常生活活动能力和手功能的影响:来自EUSTAR队列分析的结果

2025-03-270
OA
Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis

在系统性硬化症患者的EUSTAR队列中,一氧化碳和超声心动图参数的肺扩散能力可识别轻度肺动脉高压

CHEST
IF8.6
2024-10-012
OAAI
CHANGES IN TREATMENT PATTERNS AND THEIR INFLUENCE ON THE OUTCOME OF SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSc-ILD) PATIENTS: AN EUSTAR ANALYSIS

治疗模式的改变及其对系统性硬化症-间质性肺病(SSc-ILD)患者预后的影响:一项EUSTAR分析

2024-06-010
PRE
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database
2024-01-303
OAAI
THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (SCLEROID) SCORE - A NEW PATIENT-REPORTED OUTCOME MEASURE FOR PATIENTS WITH SYSTEMIC SCLEROSIS PRELIMINARY RESULTS FROM THE ONGOING VALIDATION STUDY
2017-06-010
OAAI
THE EULAR SYSTEMIC SCLEROSIS IMPACT OF DISEASE (SCLEROID) SCORE - A NEW PATIENT-REPORTED OUTCOME MEASURE FOR PATIENTS WITH SYSTEMIC SCLEROSIS UNDER DEVELOPMENT
2016-06-010
PRE